Citation Impact
Citing Papers
Identification of a Biphasic Role for Genistein in the Regulation of Prostate Cancer Growth and Metastasis
2009
Systematic Review of Pretreatment Prostate-Specific Antigen Velocity and Doubling Time As Predictors for Prostate Cancer
2008
Use of Statins and the Risk of Death in Patients With Prostate Cancer
2013
Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US
2023
Cancer statistics, 2022
2022 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I
2016 Standout
Cancer statistics, 2023
2023 Standout
Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring
2021 StandoutNobel
The changing incidence of thyroid cancer
2016
Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics
2016
Cancer statistics, 2017
2017 Standout
Cancer statistics, 2020
2020 Standout
Cancer statistics, 2024
2024 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer statistics, 2019
2019 Standout
Cancer statistics, 2018
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Cancer Statistics, 2021
2021 Standout
Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease
2015
Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor
2014 StandoutNobel
Evidence for overuse of medical services around the world
2017
The Proteome of Primary Prostate Cancer
2015
Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature
2015
Short-term and long-term effects of caesarean section on the health of women and children
2018 Standout
Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
2009
A fully automatic computer aided diagnosis system for peripheral zone prostate cancer detection using multi-parametric magnetic resonance imaging
2015
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study
2013
PROMIS — Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer
2015
Nomograms in oncology: more than meets the eye
2015 Standout
Long Noncoding RNAs in Cancer Pathways
2016 Standout
Ultrahigh sensitivity made simple: nanoplasmonic label-free biosensing with an extremely low limit-of-detection for bacterial and cancer diagnostics
2009
Epidemiology of prostate cancer in the Asia-Pacific region
2013
The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA
2016
Why cancer screening has never been shown to “save lives”—and what we can do about it
2016
Live-cell phenotypic-biomarker microfluidic assay for the risk stratification of cancer patients via machine learning
2018
High-performance medicine: the convergence of human and artificial intelligence
2018 Standout
Early Detection of Prostate Cancer: European Association of Urology Recommendation
2013
The Perseus computational platform for comprehensive analysis of (prote)omics data
2016 Standout
Bladder cancer
2016 Standout
Prostate Cancer: Can Multiparametric MR Imaging Help Identify Patients Who Are Candidates for Active Surveillance?
2013
Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice
2023
Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
2014
An Analysis of Radical Prostatectomy in Advanced Stage and High-Grade Prostate Cancer
2007
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
2010
The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men
2014
EAU Guidelines on Interventional Treatment for Urolithiasis
2015 Standout
Discordant total and free prostate-specific antigen (PSA) assays: does calibration with WHO reference materials diminish the problem?
2009
Recurrent gene fusions in prostate cancer
2008
A Prospective, Blinded Comparison of Magnetic Resonance (MR) Imaging–Ultrasound Fusion and Visual Estimation in the Performance of MR-targeted Prostate Biopsy: The PROFUS Trial
2013
Neurovascular Structure-adjacent Frozen-section Examination (NeuroSAFE) Increases Nerve-sparing Frequency and Reduces Positive Surgical Margins in Open and Robot-assisted Laparoscopic Radical Prostatectomy: Experience After 11 069 Consecutive Patients
2012
A Contemporary Update on Pathology Reporting for Prostate Cancer: Biopsy and Radical Prostatectomy Specimens
2012
An Update on Occupation and Prostate Cancer
2014
Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study
2015
Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline
2018
Active Surveillance for Prostate Cancer: A Review
2010
Artificial intelligence in radiology
2018 Standout
Cost-effectiveness of Magnetic Resonance (MR) Imaging and MR-guided Targeted Biopsy Versus Systematic Transrectal Ultrasound–Guided Biopsy in Diagnosing Prostate Cancer: A Modelling Study from a Health Care Perspective
2013
Clinical multi-omics strategies for the effective cancer management
2017
Aberrant PSA glycosylation—a sweet predictor of prostate cancer
2013
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Enhancement of sensitivity using hybrid stimulus for the diagnosis of prostate cancer based on polydiacetylene (PDA) supramolecules
2010
Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis
2017
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods
2015
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates
2019
Hemostatic Agents and Instruments in Laparoscopic Renal Surgery
2008
Bovine Serum Albumin Glutaraldehyde for Completely Sutureless Laparoscopic Heminephrectomy in a Survival Porcine Model
2010 StandoutNobel
Use of Active Surveillance vs Definitive Treatment Among Men With Low- and Favorable Intermediate–Risk Prostate Cancer in the US Between 2010 and 2018
2023
Hepatocellular Carcinoma
2019 Standout
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Proteomics biomarkers for solid tumors: Current status and future prospects
2018
Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men
2022
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
Between-Method Differences in Prostate-Specific Antigen Assays Affect Prostate Cancer Risk Prediction by Nomograms
2011
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Vibrational spectroscopy of liquid biopsies for prostate cancer diagnosis
2020
Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?
2014
Cancer statistics in China, 2015
2016 Standout
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
2016 Standout
Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment
2023
National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen–Based Screening
2015
The Prevalence of Clinically Significant Prostate Cancer According to Commonly Used Histological Thresholds in Men Undergoing Template Prostate Mapping Biopsies
2015
Localized Surface Plasmon Resonance Sensors
2011 Standout
Exposure of Human Prostaspheres to Bisphenol A Epigenetically Regulates SNORD Family Noncoding RNAs via Histone Modification
2015
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
The novel prostate cancer antigen 3 (PCA3) biomarker
2010
Prostate cancer screening in African American men: a review of the evidence
2023
Reconsidering the Trade-offs of Prostate Cancer Screening
2020
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
2017
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Cancer statistics, 2016
2016 Standout
Cancer statistics, 2015
2015 Standout
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Water-Soluble Conjugated Polymers for Imaging, Diagnosis, and Therapy
2012 Standout
Metastatic Prostate Cancer
2018
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation
2013
Sutureless Laparoscopic Heminephrectomy: Safety and Efficacy in Physiologic and Chronically Obstructed Porcine Kidney
2008
Changes in Prostate-Specific Antigen Testing Relative to the Revised US Preventive Services Task Force Recommendation on Prostate Cancer Screening
2021
Global cancer statistics, 2012
2015 Standout
Transperineal template prostate‐mapping biopsies: an evaluation of different protocols in the detection of clinically significant prostate cancer
2015
Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART II
2016 Standout
Screening for Prostate Cancer With the Prostate-Specific Antigen Test
2014
Chitosan-stabilized platinum nanoparticles as effective oxidase mimics for colorimetric detection of acid phosphatase
2017
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations
2015
Patterns of Repeat Prostate Biopsy in Contemporary Clinical Practice
2014
Prostate-Specific Antigen–Based Screening for Prostate Cancer
2018
Grade Migration of Prostate Cancer in the United States During the Last Decade
2022
Expected population impacts of discontinued prostate‐specific antigen screening
2014
Pretreatment Prostate-Specific Antigen (PSA) Velocity and Doubling Time Are Associated With Outcome but Neither Improves Prediction of Outcome Beyond Pretreatment PSA Alone in Patients Treated With Radical Prostatectomy
2009
Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer
2015 Standout
Works of Stacy Loeb being referenced
Prostate-Specific Antigen Kinetics During Follow-Up Are an Unreliable Trigger for Intervention in a Prostate Cancer Surveillance Program
2010
Prostate-specific antigen screening: pro
2010
Beyond prostate-specific antigen
2016
Active Surveillance for Prostate Cancer: A Systematic Review of Clinicopathologic Variables and Biomarkers for Risk Stratification
2014
Systematic Review of Complications of Prostate Biopsy
2013
Prostate Cancer Imaging Trends After a Nationwide Effort to Discourage Inappropriate Prostate Cancer Imaging
2013
Exploring Variation in the Use of Conservative Management for Low-risk Prostate Cancer in the Veterans Affairs Healthcare System
2020
Prostate cancer risk assessment tools in an unscreened population
2014
Assay Standardization Bias: Different Prostate Cancer Detection Rates and Clinical Outcomes Resulting from Different Assays for Free and Total Prostate-Specific Antigen
2007
Environmental exposures and prostate cancer
2012
Prostate-specific antigen in clinical practice
2007
Genomic Predictors of Outcome in Prostate Cancer
2015
Use of BioGlue in laparoscopic partial nephrectomy
2006
The Vanishing Prostate Cancer Phenomenon
2010
Does perineural invasion on prostate biopsy predict adverse prostatectomy outcomes?
2009
Active surveillance for prostate cancer: current evidence and contemporary state of practice
2016
The Prostate Health Index
2015
A Systematic Review on Guidelines and Recommendations for Urology Standard of Care During the COVID-19 Pandemic
2020
Outcomes of a Bladder Cancer Screening Program Using Home Hematuria Testing and Molecular Markers
2013
Complications After Systematic, Random, and Image-guided Prostate Biopsy
2016
Overdiagnosis and Overtreatment of Prostate Cancer
2014
Intermediate-Term Potency, Continence, and Survival Outcomes of Radical Prostatectomy for Clinically High-Risk or Locally Advanced Prostate Cancer
2007
Is statin use associated with prostate cancer aggressiveness?
2009
Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old
2006
Prestenting Improves Ureteroscopic Stone-Free Rates
2007
Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden
2016
Complications After Prostate Biopsy: Data From SEER-Medicare
2011
Prostate Specific Antigen Testing Among the Elderly—When To Stop?
2009
Prostate Specific Antigen Velocity Threshold for Predicting Prostate Cancer in Young Men
2007
The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer
2014
1026: Combined PSA Density and Biopsy Features to Predict "Clinically Insignificant" Prostate Cancer
2007
A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
2011
Delay of Surgery in Men With Low Risk Prostate Cancer
2011
Under Diagnosis and Over Diagnosis of Prostate Cancer
2007
Risk of Prostate Cancer for Young Men With a Prostate Specific Antigen Less Than Their Age Specific Median
2007
A Prospective Study of Laparoscopic Radical Nephrectomy for T1 Tumors—Is Transperitoneal, Retroperitoneal or Hand Assisted the Best Approach?
2006
Prediction of Prostate Cancer Risk: The Role of Prostate Volume and Digital Rectal Examination in the ERSPC Risk Calculators
2011
Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015
2018
Biomarkers for Prostate Cancer
2008
Accuracy of PCA3 Measurement in Predicting Short-Term Biopsy Progression in an Active Surveillance Program
2009
Population Based Study of Use and Determinants of Active Surveillance and Watchful Waiting for Low and Intermediate Risk Prostate Cancer
2013
Comparison of Gonadotropin-Releasing Hormone Agonists and Orchiectomy
2015
Twitter response to the United States Preventive Services Task Force recommendations against screening with prostate‐specific antigen
2014
The Association of Veterans’ PSA Screening Rates With Changes in USPSTF Recommendations
2020
Population Based Study of Predictors of Adverse Pathology among Candidates for Active Surveillance with Gleason 6 Prostate Cancer
2013
Postoperative mortality 90 days after robot‐assisted laparoscopic prostatectomy and retropubic radical prostatectomy: a nationwide population‐based study
2016
Pathological Characteristics of Prostate Cancer Detected Through Prostate Specific Antigen Based Screening
2006
Prostate Specific Antigen Assay Standardization Bias Could Affect Clinical Decision Making
2008
What Is the True Number Needed to Screen and Treat to Save a Life With Prostate-Specific Antigen Testing?
2010
The Prostate Health Index: a new test for the detection of prostate cancer
2013
What to Do with an Abnormal PSA Test
2008
Comparison of Methods for Calculating Prostate Specific Antigen Velocity
2006
476: Underdiagnosis and Overdiagnosis of Prostate Cancer
2006
The M elbourne Consensus Statement on the early detection of prostate cancer
2013